269 related articles for article (PubMed ID: 31914064)
21. 18F-fluorocholine PET/MRI versus ultrasound and sestamibi for the localization of parathyroid adenomas.
Noltes ME; Rotstein L; Eskander A; Kluijfhout WP; Bongers P; Brouwers AH; Kruijff S; Metser U; Pasternak JD; Veit-Haibach P
Langenbecks Arch Surg; 2023 Apr; 408(1):155. PubMed ID: 37079138
[TBL] [Abstract][Full Text] [Related]
22. Dual-Time-Point
Broos WAM; Wondergem M; van der Zant FM; Knol RJJ
J Nucl Med; 2019 Nov; 60(11):1605-1610. PubMed ID: 30877179
[No Abstract] [Full Text] [Related]
23. Parathyroid imaging by (18)F-fluorocholine PET/CT in patients with primary hyperparathyroidism and inconclusive conventional methods: clinico-pathological correlations.
Zajíčková K; Zogala D; Kubinyi J
Physiol Res; 2018 Nov; 67(Suppl 3):S551-S557. PubMed ID: 30484682
[TBL] [Abstract][Full Text] [Related]
24. ¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study.
Lezaic L; Rep S; Sever MJ; Kocjan T; Hocevar M; Fettich J
Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2083-9. PubMed ID: 25063039
[TBL] [Abstract][Full Text] [Related]
25. FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography.
Koumakis E; Gauthé M; Martinino A; Sindayigaya R; Delbot T; Wartski M; Clerc J; Roux C; Borderie D; Cochand-Priollet B; Cormier C; Gaujoux S
J Clin Endocrinol Metab; 2023 Jul; 108(8):1958-1967. PubMed ID: 36750257
[TBL] [Abstract][Full Text] [Related]
26.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
27.
Boccalatte LA; Gómez NL; Musumeci M; Galich AM; Collaud C; Figari MF
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):273-278. PubMed ID: 32540340
[TBL] [Abstract][Full Text] [Related]
28. A cost-utility analysis of 18F-fluorocholine-positron emission tomography imaging for localizing primary hyperparathyroidism in the United States.
Yap A; Hope TA; Graves CE; Kluijfhout W; Shen WT; Gosnell JE; Sosa JA; Roman SA; Duh QY; Suh I
Surgery; 2022 Jan; 171(1):55-62. PubMed ID: 34340823
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic Performance of 99mTc-Sestamibi SPECT/CT and 18F-Choline PET/CT in Locating Hyperfunctioning Parathyroid Glands in Patients with Primary Hyperparathyroidism.
Mandic A; Kraljevic I; Skoric Polovina T; Zibar Tomsic K; Dusek T; Balasko A; Solak M; Kastelan D
Exp Clin Endocrinol Diabetes; 2024 Apr; 132(4):216-220. PubMed ID: 38320618
[TBL] [Abstract][Full Text] [Related]
30. 18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center.
Talbot JN; Périé S; Tassart M; Delbot T; Aveline C; Zhang-Yin J; Kerrou K; Gaujoux S; Wagner I; Bennis M; Ménégaux F; Breton S; Cochand-Priollet B; Christin-Maitre S; Groussin L; Haymann JP; Baujat B; Balogova S; Montravers F
Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):96-113. PubMed ID: 36995286
[TBL] [Abstract][Full Text] [Related]
31. Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT. Illustrative cases and pitfalls.
Talbot JN; Zhang-Yin J; Kerrou K; Aveline C; Vagne B; Bélissant O; Tassart M; Périé S; Bouchard P; Christin-Maitre S; Ménégaux F; Groussin L; Gaujoux S; Balogová S; Montravers F
Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):130-140. PubMed ID: 35005879
[No Abstract] [Full Text] [Related]
32. The EANM practice guidelines for parathyroid imaging.
Petranović Ovčariček P; Giovanella L; Carrió Gasset I; Hindié E; Huellner MW; Luster M; Piccardo A; Weber T; Talbot JN; Verburg FA
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2801-2822. PubMed ID: 33839893
[TBL] [Abstract][Full Text] [Related]
33. Comparison of Neck Ultrasonography, Dual Phase
Abhishek B; Wakankar R; Dharmashaktu Y; Damle NA; Kumar P; Bal C; Tripathi M; Kandasamy D; Khadgawat R; Agarwal S; Vuthaluru S; Chumber S
Indian J Nucl Med; 2023; 38(3):208-217. PubMed ID: 38046978
[TBL] [Abstract][Full Text] [Related]
34.
Christakis I; Khan S; Sadler GP; Gleeson FV; Bradley KM; Mihai R
Ann R Coll Surg Engl; 2019 Sep; 101(7):501-507. PubMed ID: 31305126
[TBL] [Abstract][Full Text] [Related]
35. Superior sensitivity of
Graves CE; Hope TA; Kim J; Pampaloni MH; Kluijfhout W; Seib CD; Gosnell JE; Shen WT; Roman SA; Sosa JA; Duh QY; Suh I
Surgery; 2022 Jan; 171(1):47-54. PubMed ID: 34301418
[TBL] [Abstract][Full Text] [Related]
36. Assessment and Comparison of
Whitman J; Allen IE; Bergsland EK; Suh I; Hope TA
J Nucl Med; 2021 Sep; 62(9):1285-1291. PubMed ID: 33452040
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Performance of F-18 Fluorocholine PET/CT for Parathyroid Localization in Hyperparathyroidism: a Systematic Review and Meta-Analysis.
Kim SJ; Lee SW; Jeong SY; Pak K; Kim K
Horm Cancer; 2018 Dec; 9(6):440-447. PubMed ID: 30121878
[TBL] [Abstract][Full Text] [Related]
38. Misleading localization by
Mukhtar NN; Abouzied MEM; Alqahtani MH; Hammami MM
BMC Endocr Disord; 2021 Jan; 21(1):20. PubMed ID: 33499837
[TBL] [Abstract][Full Text] [Related]
39. Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism.
Tlili G; Mesguich C; Gaye D; Tabarin A; Haissaguerre M; Hindié E
Q J Nucl Med Mol Imaging; 2023 Jun; 67(2):114-121. PubMed ID: 36748984
[TBL] [Abstract][Full Text] [Related]
40. Enabling minimal invasive parathyroidectomy for patients with primary hyperparathyroidism using Tc-99m-sestamibi SPECT-CT, ultrasound and first results of (18)F-fluorocholine PET-CT.
Kluijfhout WP; Vorselaars WM; Vriens MR; Borel Rinkes IH; Valk GD; de Keizer B
Eur J Radiol; 2015 Sep; 84(9):1745-51. PubMed ID: 26047823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
